ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

ATOS Atossa Therapeutics Inc

1.53
0.01 (0.66%)
プレマーケット
最終更新日: 18:30:01
15分遅延
名称 銘柄コード 市場 種別
Atossa Therapeutics Inc ATOS NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.01 0.66% 1.53 18:30:01
始値 安値 高値 終値 前日終値
1.52
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2921:30GLOBEAtossa Therapeutics Announces Expanded Research Agreement..
2024/4/1521:30GLOBEAtossa Therapeutics and Quantum Leap Healthcare Announce..
2024/4/1121:30GLOBEAtossa to Participate in Noble Capital Markets Emerging..
2024/4/1000:59GLOBEAtossa Therapeutics Presents Data from 40mg Cohort of Phase..
2024/4/0205:00GLOBEAtossa Therapeutics Announces Year-End 2023 Financial..
2024/3/1921:30GLOBEAtossa Therapeutics Provides Five-Year (Z)-Endoxifen..
2024/3/1821:30GLOBEAtossa Therapeutics Regains Compliance with Nasdaq Minimum..
2024/3/1221:30GLOBEAtossa Therapeutics Appoints Breast Cancer Specialist Tessa..
2024/2/2222:30GLOBEAtossa Therapeutics Announces First Patient Dosing of..
2024/2/0722:30GLOBEAtossa Therapeutics Announces Full Enrollment..
2024/1/0922:30GLOBEAtossa Therapeutics Issues Letter to Shareholders
2023/12/0422:30GLOBEAtossa Therapeutics Announces the Appointment of Arezoo..
2023/11/2022:30GLOBEAtossa Therapeutics Announces Full Enrollment of Phase 2..
2023/11/1607:03EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
2023/11/1606:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/11/1606:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1323:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1323:00EDGAR2Form 8-K - Current report
2023/11/1323:00GLOBEAtossa Therapeutics Announces Third Quarter 2023 Financial..
2023/11/0923:00EDGAR2Form 8-K - Current report
2023/11/0923:00GLOBEAtossa Therapeutics Appoints Financial Executive Jonathan..
2023/10/3102:00PRNUSQuantum Leap Healthcare Collaborative Initiates Landmark..
2023/10/1705:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/10/1121:30PRNUSFast-food consumption by adolescent girls may sow the seeds..
2023/10/0705:00EDGAR2Form 8-K - Current report
2023/9/2905:28EDGAR2Form 8-K - Current report
2023/9/1821:30GLOBEAtossa to Present at Cantor Fitzgerald Global Healthcare..
2023/8/1421:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1421:30EDGAR2Form 8-K - Current report
2023/8/1421:30GLOBEAtossa Therapeutics Announces Second Quarter 2023 Financial..
2023/8/0822:00GLOBEAtossa Therapeutics to Provide Business Update and Report..
2023/7/2022:15GLOBEAtossa Therapeutics Receives Approval from Health Canada to..
2023/7/1405:20EDGAR2Form 8-K - Current report
2023/7/1405:15GLOBEAtossa Therapeutics Regains Compliance with Nasdaq Minimum..
2023/7/1022:15GLOBEAtossa Therapeutics Provides Enrollment Update for Ongoing..
2023/7/0622:15GLOBEAtossa Therapeutics Announces Sponsored Research Agreement..
2023/6/2822:15GLOBEAtossa Therapeutics and Quantum Leap Healthcare Provide..
2023/6/2822:01EDGAR2Form 8-K - Current report
2023/6/2722:15GLOBEAtossa Therapeutics Announces $10M Stock Repurchase Program
2023/6/2305:15GLOBEAtossa Therapeutics Announces Sponsorship of Are You Dense..
2023/6/2123:13GLOBEAtossa Therapeutics Granted Additional Patent Protection for..
2023/6/1422:15GLOBEAtossa to Participate in Fireside Chat at Healthcare Virtual..
2023/6/1222:15GLOBEAtossa Completes Enrollment of Pharmacokinetic Run-In Cohort..
2023/6/0122:10GLOBEAtossa Appoints Life Sciences Financial and Operations..
2023/5/2320:00GLOBESocietal CDMO Enters Agreement With Atossa Therapeutics to..
2023/5/1522:10GLOBEAtossa Therapeutics Announces First Quarter 2023 Financial..
2023/5/1122:00PRNUSPhysician-Scientist Dr. Steven Quay Provides Recommendations..
2023/5/0922:15GLOBEAtossa to Present a Trial in Progress Poster on its..

最近閲覧した銘柄

Delayed Upgrade Clock